July 15, 2026 · Form 4 insider transaction
LO FRANCIS bought 22,711 shares of Adaptive Biotechnologies Corporation at $8.46 per share, a transaction worth $192.1K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025.